Search research articles
Contact Us
Filters
Showing results (121-130 of 154) with videos related to
Page
of 16
Sort By:
The Journal of Clinical Investigation
|
April 15, 2021
TYRO3 induces anti-PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis
Zhou Jiang, Seung-Oe Lim, Meisi Yan, et al.
Cancer Cell
|
February 12, 2015
14-3-3ζ turns TGF-β's function from tumor suppressor to metastasis promoter in breast cancer by contextual changes of Smad partners from p53 to Gli2
Jia Xu, Sunil Acharya, Ozgur Sahin, et al.
Cancer Cell
|
November 25, 2021
The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1
Hongzhong Li, Yi Xiao, Qin Li, et al.
Cancer Research
|
September 19, 2015
Src Inhibition Blocks c-Myc Translation and Glucose Metabolism to Prevent the Development of Breast Cancer
Shalini Jain, Xiao Wang, Chia-Chi Chang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 7, 2011
Phase I/II study of trastuzumab in combination with everolimus (RAD001) in patients with HER2-overexpressing metastatic breast cancer who progressed on trastuzumab-based therapy
Phuong K Morrow, Gerburg M Wulf, Joe Ensor, et al.
Cell
|
October 27, 2018
The Skp2-SCF E3 Ligase Regulates Akt Ubiquitination, Glycolysis, Herceptin Sensitivity, and Tumorigenesis
Chia-Hsin Chan, Chien-Feng Li, Wei-Lei Yang, et al.
Cell
|
May 29, 2012
The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis
Chia-Hsin Chan, Chien-Feng Li, Wei-Lei Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2005
A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas
Jeremy D Henson, Jonathan A Hannay, Stanley W McCarthy, et al.
Nature Cell Biology
|
September 20, 2024
Astrocyte-induced Cdk5 expedites breast cancer brain metastasis by suppressing MHC-I expression to evade immune recognition
Arseniy E Yuzhalin, Frank J Lowery, Yohei Saito, et al.
Nature
|
October 20, 2015
Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth
Lin Zhang, Siyuan Zhang, Jun Yao, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 154) with videos related to
Sort By:
Page
of 16
The Journal of Clinical Investigation
|
April 15, 2021
TYRO3 induces anti-PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis
Zhou Jiang, Seung-Oe Lim, Meisi Yan, et al.
Cancer Cell
|
February 12, 2015
14-3-3ζ turns TGF-β's function from tumor suppressor to metastasis promoter in breast cancer by contextual changes of Smad partners from p53 to Gli2
Jia Xu, Sunil Acharya, Ozgur Sahin, et al.
Cancer Cell
|
November 25, 2021
The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1
Hongzhong Li, Yi Xiao, Qin Li, et al.
Cancer Research
|
September 19, 2015
Src Inhibition Blocks c-Myc Translation and Glucose Metabolism to Prevent the Development of Breast Cancer
Shalini Jain, Xiao Wang, Chia-Chi Chang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 7, 2011
Phase I/II study of trastuzumab in combination with everolimus (RAD001) in patients with HER2-overexpressing metastatic breast cancer who progressed on trastuzumab-based therapy
Phuong K Morrow, Gerburg M Wulf, Joe Ensor, et al.
Cell
|
October 27, 2018
The Skp2-SCF E3 Ligase Regulates Akt Ubiquitination, Glycolysis, Herceptin Sensitivity, and Tumorigenesis
Chia-Hsin Chan, Chien-Feng Li, Wei-Lei Yang, et al.
Cell
|
May 29, 2012
The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis
Chia-Hsin Chan, Chien-Feng Li, Wei-Lei Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2005
A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas
Jeremy D Henson, Jonathan A Hannay, Stanley W McCarthy, et al.
Nature Cell Biology
|
September 20, 2024
Astrocyte-induced Cdk5 expedites breast cancer brain metastasis by suppressing MHC-I expression to evade immune recognition
Arseniy E Yuzhalin, Frank J Lowery, Yohei Saito, et al.
Nature
|
October 20, 2015
Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth
Lin Zhang, Siyuan Zhang, Jun Yao, et al.
Page
of 16